Literature DB >> 22874759

Disorder of fatty acid metabolism in the kidney of PAN-induced nephrotic rats.

Yoshikazu Muroya1, Osamu Ito, Rong Rong, Kenta Takashima, Daisuke Ito, Pengyu Cao, Yasuhiro Nakamura, Kensuke Joh, Masahiro Kohzuki.   

Abstract

Proteinuria is considered to play an essential role in the progression of tubulointerstitial damage, which causes end-stage renal disease. Fatty acid-binding albumins are filtered through glomeruli and reabsorbed into proximal tubular epithelial cells (PTECs). However, the role of fatty acid metabolism associated with albuminuria in the development of tubulointerstitial damage remains unclear. Thus, the present study was designed to determine the changes of fatty acid metabolism in the nephrotic kidney. To induce nephrotic syndrome, Sprague-Dawley rats (SDRs) and Nagase analbuminemic rats (NARs) with inherited hypoalbuminemia were treated with a single injection of puromycin aminonucleoside (PAN). In SDRs, PAN treatment induced massive proteinuria and albuminuria and caused tubular damage, apoptosis, and lipid accumulation in PTECs. Among the enzymes of fatty acid metabolism, expressions of medium-chain acyl-CoA dehydrogenase (MCAD) and cytochrome P-450 (CYP)4A significantly decreased in PTECs of PAN-treated SDRs. Expressions of peroxisome proliferator-activated receptor (PPAR)-γ coactivator (PGC)-1α and estrogen-related receptor (ERR)α also significantly decreased, without changes in the expression of PPAR-α. In NARs, PAN treatment induced proteinuria but not albuminuria and did not cause tubular damage, apoptosis, or lipid accumulation. Expressions of MCAD, PGC-1α, or ERRα did not change in the kidney cortex of PAN-treated NARs, but the expression of CYP4A significantly decreased. These results indicate that massive albuminuria causes tubular damage and lipid accumulation with the reduction of MCAD, CYP4A, PGC-1α, and ERRα in PTECs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22874759     DOI: 10.1152/ajprenal.00365.2011

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  6 in total

1.  Effect of clofibrate on fatty acid metabolism in the kidney of puromycin-induced nephrotic rats.

Authors:  Yoshikazu Muroya; Osamu Ito
Journal:  Clin Exp Nephrol       Date:  2016-03-07       Impact factor: 2.801

Review 2.  Kidneys: key modulators of high-density lipoprotein levels and function.

Authors:  Haichun Yang; Agnes B Fogo; Valentina Kon
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-05       Impact factor: 2.894

3.  Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy.

Authors:  Michal Herman-Edelstein; Pnina Scherzer; Ana Tobar; Moshe Levi; Uzi Gafter
Journal:  J Lipid Res       Date:  2013-12-26       Impact factor: 5.922

4.  Yi Qi Qing Re Gao formula ameliorates puromycin aminonucleoside-induced nephrosis by suppressing inflammation and apoptosis.

Authors:  Yumin Wen; Yongli Zhan; Huijie Liu; Tingting Zhao; Liping Yang; Haojun Zhang; Xi Dong; Ping Li
Journal:  BMC Complement Altern Med       Date:  2015-05-27       Impact factor: 3.659

5.  Detecting serum and urine metabolic profile changes of CCl4-liver fibrosis in rats at 12 weeks based on gas chromatography-mass spectrometry.

Authors:  Jiarong Gao; Xiu-Juan Qin; Hui Jiang; Jin-Feng Chen; Ting Wang; Ting Zhang; Shuang-Zhi Xu; Jun-Mei Song
Journal:  Exp Ther Med       Date:  2017-06-26       Impact factor: 2.447

6.  TLR-mediated albuminuria needs TNFα-mediated cooperativity between TLRs present in hematopoietic tissues and CD80 present on non-hematopoietic tissues in mice.

Authors:  Nidhi Jain; Bhavya Khullar; Neelam Oswal; Balaji Banoth; Prashant Joshi; Balachandran Ravindran; Subrat Panda; Soumen Basak; Anna George; Satyajit Rath; Vineeta Bal; Shailaja Sopory
Journal:  Dis Model Mech       Date:  2016-04-28       Impact factor: 5.758

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.